Immuno AG

Immuno AG was a major[1] Pharmaceutical company founded in 1960 by Dr. Otto Schwarz & Dr. Hans Eibl[2] with headquarters in Vienna, Austria.[3]

In 1996 the company was acquired by Baxter for $715 Million.[4]

Business

Immuno manufactured blood products including Factor VIII and Factor IX[5] such as Kryobulin and Krobulin TIM.[6]

Lawsuits

In 1983 Immuno sued Dr. Shirley McGreal and several others claiming $4 million in damages for an article claiming the company planned to use captured chimpanzees for hepatitis research in Sierra Leone.[7][8]

In 1986 two civil lawsuits were brought against Immuno by the Association Against Animal Experimentation in regards to treatment of Chimpanzees.[9]

References
  1. Whiteside, R. M.; Wilson, A.; Blackburn, S.; Hörnig, S. E.; Wilson, C. P. (6 December 2012). Major Companies of Europe 1990/91 Volume 3: Major Companies of Western Europe Outside the European Economic Community. Springer Science & Business Media. ISBN 9789400908017 – via Google Books.
  2. Stern, Joe. "In Memoriam of Dr. Otto Schwarz - Plasma Protein Therapeutics Association (PPTA)".
  3. "Immuno AG".
  4. Thomas M. Burton (30 August 1996). "Baxter Confirms Pact To Acquire Immuno". Wall Street Journal.
  5. "Method of producing a factor-VIII(AHF)-high-concentrate".
  6. "Final Report: Chapter 23 - Viral Inactivation of Blood Products for Haemophilia Therapy up to 1985".
  7. "Abroad at Home; Abusing The Law". The New York Times. 10 May 1991.
  8. "IMMUNO, A.G., APPELLANT, v. JAN MOOR-JANKOWSKI, RESPONDENT".
  9. Information, Reed Business (21 August 1986). "New Scientist". Reed Business Information – via Google Books.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.